Back to MLTX

UBS Group AG → MLTX

UBS Group AG MLTX Position History

MoonLake Immunotherapeutics • Healthcare

Quarters held
14
Latest value
$4.4M
Q3 2026
Peak value
$6.4M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$1K
Q3 2025$576K
Q3 2025$22K
Q3 2025$6K
Q4 2025$3.1M
Q4 2025$4K
Q4 2025$59K
Q1 2026$15K
Q1 2026$52K
Q1 2026$6K
Q2 2026$21K
Q2 2026$6.4M
Q2 2026$6K
Q3 2026$4.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$4.4M377.3K——
Q2 2026$6K300——
Q2 2026$6.4M327.1K——
Q2 2026$21K1.1K——
Q1 2026$6K300——
Q1 2026$52K2.8K——
Q1 2026$15K802——
Q4 2025$59K4.5K——
Q4 2025$4K300——
Q4 2025$3.1M234.3K——
Q3 2025$6K820——
Q3 2025$22K3.0K——
Q3 2025$576K80.3K——
Q3 2025$1K209——

Other funds holding MLTX

$311.5M
$298.3M
$260.3M
$256.4M
$192.9M
$191.2M
$187.2M
$182.6M

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B